At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 263 enrolled
Drug / intervention
ketorolac eye dropsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating ketorolac eye drops for Cataract Extraction. Completed, enrolled 263 participants across 1 site.
Detailed Summary
This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract Extraction
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 2007
Enrollment StartOct 2007
Primary CompletionMar 2008
TodayJul 2026
First PostedAug 27, 2007
Enrollment StartOct 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.8 years ago
Interventions
ketorolac eye dropsdrug
1 drop twice daily day preop and Days 1-14, and 6 doses on surgery day Placebo